BMI 0 3 0 3 B-bmi
> 4 5 4 5 O
40 6 8 6 8 B-lower_bound
kg 9 11 9 11 I-lower_bound
/ 11 12 11 12 I-lower_bound
m2 12 14 12 14 I-lower_bound

Patients 0 8 15 23 O
on 9 11 24 26 O
chronic 12 19 27 34 B-treatment
glucocorticoids 20 35 35 50 I-treatment
( 36 37 51 52 O
except 37 43 52 58 O
nasal 44 49 59 64 O
preparations 50 62 65 77 O
) 62 63 77 78 O
, 63 64 78 79 O
or 65 67 80 82 O
using 68 73 83 88 O
glucocorticoids 74 89 89 104 O
for 90 93 105 108 O
assisted 94 102 109 117 O
hatching 103 111 118 126 O

Patients 0 8 127 135 O
on 9 11 136 138 O
monoclonal 12 22 139 149 B-treatment
antibody 23 31 150 158 I-treatment
preparations 32 44 159 171 I-treatment
directed 45 53 172 180 I-treatment
to 54 56 181 183 I-treatment
TNFα 57 61 184 188 I-treatment

Post 0 4 189 193 O
- 4 5 193 194 O
enrollment 5 15 194 204 O
exclusion 16 25 205 214 O
will 26 30 215 219 O
include 31 38 220 227 O
patients 39 47 228 236 O
receiving 48 57 237 246 O
any 58 61 247 250 O
antibiotics 62 73 251 262 B-treatment
, 73 74 262 263 O
except 75 81 264 270 O
prophylaxis 82 93 271 282 B-treatment
for 94 97 283 286 O
transvaginal 98 110 287 299 B-treatment
oocyte 111 117 300 306 I-treatment
retrieval 118 127 307 316 I-treatment
( 128 129 317 318 I-treatment
TVOR 129 133 318 322 I-treatment
) 133 134 322 323 I-treatment
or 135 137 324 326 O
glucocorticoids 138 153 327 342 B-treatment
, 153 154 342 343 O
except 155 161 344 350 O
nasal 162 167 351 356 O
preparations 168 180 357 369 O
, 180 181 369 370 O
from 182 186 371 375 O
the 187 190 376 379 O
time 191 195 380 384 O
of 196 198 385 387 O
endometrial 199 210 388 399 B-treatment
biopsy 211 217 400 406 I-treatment
until 218 223 407 412 O
initial 224 231 413 420 O
transvaginal 232 244 421 433 O
ultrasound 245 255 434 444 O
( 256 257 445 446 O
TVUS 257 261 446 450 O
) 261 262 450 451 O
for 263 266 452 455 O
pregnancy 267 276 456 465 B-pregnancy

age 0 3 466 469 B-age
of 4 6 470 472 O
≥ 7 8 473 474 O
21 9 11 475 477 B-lower_bound
and 12 15 478 481 O
≤ 16 17 482 483 O
35 18 20 484 486 B-upper_bound
years 21 26 487 492 I-upper_bound
old 27 30 493 496 O

anti 0 4 497 501 B-clinical_variable
- 4 5 501 502 I-clinical_variable
mullerian 5 14 502 511 I-clinical_variable
hormone 15 22 512 519 I-clinical_variable
( 23 24 520 521 I-clinical_variable
AMH 24 27 521 524 I-clinical_variable
) 27 28 524 525 I-clinical_variable
< 29 30 526 527 O
1.0 31 34 528 531 B-upper_bound
ng 35 37 532 534 I-upper_bound
/ 37 38 534 535 I-upper_bound
mL 38 40 535 537 I-upper_bound

antral 0 6 538 544 B-clinical_variable
follicle 7 15 545 553 I-clinical_variable
count 16 21 554 559 I-clinical_variable
< 22 23 560 561 O
10 23 25 561 563 B-upper_bound

positive 0 8 564 572 O
gonorrhea 9 18 573 582 B-chronic_disease
and 19 22 583 586 O
chlamydia 23 32 587 596 B-chronic_disease
DNA 33 36 597 600 O
testing 37 44 601 608 O

presence 0 8 609 617 O
of 9 11 618 620 O
an 12 14 621 623 O
endometrial 15 26 624 635 B-chronic_disease
polyp 27 32 636 641 I-chronic_disease
or 33 35 642 644 O
endometrial 36 47 645 656 B-chronic_disease
synechiae 48 57 657 666 I-chronic_disease

presence 0 8 667 675 O
of 9 11 676 678 O
type 12 16 679 683 O
4 17 18 684 685 B-cancer
fibroid 19 26 686 693 I-cancer
tumor 27 32 694 699 I-cancer
with 33 37 700 704 O
a 38 39 705 706 O
mean 40 44 707 711 O
diameter 45 53 712 720 B-clinical_variable
of 54 56 721 723 O
> 57 58 724 725 O
4 59 60 726 727 B-lower_bound
cm 61 63 728 730 I-lower_bound

previous 0 8 731 739 B-treatment
endometrial 9 20 740 751 I-treatment
ablation 21 29 752 760 I-treatment

previous 0 8 761 769 O
uterine 9 16 770 777 B-treatment
artery 17 23 778 784 I-treatment
embolization 24 36 785 797 I-treatment

